These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33631419)

  • 1. Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B).
    Ding Y; O'Brien A; Marcó de la Cruz B; Yang M; Lu Y; Qian X; Yang G; McInerney V; Krawczyk J; Lynch SA; Howard L; Allen NM; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2021 May; 53():102254. PubMed ID: 33631419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B).
    Ding Y; O'Brien A; de la Cruz BM; Yang M; Fitzgerald J; Yang G; Li W; McInerney V; Krawczyk J; Lynch SA; Howard L; Allen NM; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2021 Apr; 52():102222. PubMed ID: 33578364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of familial iPSC lines from three ASD patients carrying NRXN1α
    Ding Y; Marcó de la Cruz B; Xia Y; Liu M; Lu Y; McInerney V; Krawczyk J; Lynch SA; Howard L; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2019 Dec; 41():101653. PubMed ID: 31759289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Ca
    Avazzadeh S; McDonagh K; Reilly J; Wang Y; Boomkamp SD; McInerney V; Krawczyk J; Fitzgerald J; Feerick N; O'Sullivan M; Jalali A; Forman EB; Lynch SA; Ennis S; Cosemans N; Peeters H; Dockery P; O'Brien T; Quinlan LR; Gallagher L; Shen S
    Mol Autism; 2019; 10():52. PubMed ID: 31893021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRXN1α
    Avazzadeh S; Quinlan LR; Reilly J; McDonagh K; Jalali A; Wang Y; McInerney V; Krawczyk J; Ding Y; Fitzgerald J; O'Sullivan M; Forman EB; Lynch SA; Ennis S; Feerick N; Reilly R; Li W; Shen X; Yang G; Lu Y; Peeters H; Dockery P; O'Brien T; Shen S; Gallagher L
    BMC Neurosci; 2021 Sep; 22(1):56. PubMed ID: 34525970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A).
    de la Cruz BM; Ding Y; McInerney V; Krawczyk J; Lu Y; Yang G; Qian X; Li W; Howard L; Allen NM; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2020 Apr; 44():101722. PubMed ID: 32097875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal impact of patient-specific aberrant NRXN1α splicing.
    Flaherty E; Zhu S; Barretto N; Cheng E; Deans PJM; Fernando MB; Schrode N; Francoeur N; Antoine A; Alganem K; Halpern M; Deikus G; Shah H; Fitzgerald M; Ladran I; Gochman P; Rapoport J; Tsankova NM; McCullumsmith R; Hoffman GE; Sebra R; Fang G; Brennand KJ
    Nat Genet; 2019 Dec; 51(12):1679-1690. PubMed ID: 31784728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of iPSC lines from three young healthy donors of Caucasian origin (NUIGi035-A; NUIGi036-A; NUIGi037-A).
    Ding Y; de la Cruz BM; McInerney V; Lu Y; Yang G; Qian X; Li W; Krawczyk J; Howard L; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2020 Dec; 49():102101. PubMed ID: 33370872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic contribution of Nrxn1α to autism-relevant behavioral phenotypes in mice.
    Xu B; Ho Y; Fasolino M; Medina J; O'Brien WT; Lamonica JM; Nugent E; Brodkin ES; Fuccillo MV; Bucan M; Zhou Z
    PLoS Genet; 2023 Feb; 19(2):e1010659. PubMed ID: 36848371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).
    Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
    Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human induced pluripotent stem cell line (QBRIi013-A) derivation from a 6-year-old female diagnosed with Autism spectrum disorder (ASD) and intellectual disability (ID).
    Elsayed AK; Salloum-Asfar S; Abdulla SA
    Stem Cell Res; 2021 Oct; 56():102500. PubMed ID: 34438163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line (SDQLCHi008-A) from a patient with ASD and DD carrying an 830 kb de novo deletion at chr7q11.22 including the exon 1 of AUTS2 gene.
    Yang X; Zhou T; Zhang H; Li Y; Dong R; Liu N; Pan G; Liu Y; Gai Z
    Stem Cell Res; 2019 Oct; 40():101557. PubMed ID: 31505389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a human induced pluripotent stem cell line (SJTUXHi002-A) from an individual with autism spectrum disorder carrying a heterozygous mutation in GRIA2.
    Ji Y; Lv H; Chen Z; Yu J; Fang S; Li F
    Stem Cell Res; 2022 Apr; 60():102676. PubMed ID: 35134694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency.
    Sampaio GLA; Martins GLS; Paredes BD; Nonaka CKV; da Silva KN; Rossi EA; Dos Santos RR; Soares MBP; Souza BSF
    Stem Cell Res; 2019 Aug; 39():101488. PubMed ID: 31272037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An induced pluripotent stem cells line (SDQLCHi014-A) derived from urine cells of a patient with ASD and hyperactivity carrying a 303 kb de novo deletion at chr3p26.1 implicating GRM7 gene.
    Yang X; Liu Y; Zhou T; Zhang H; Dong R; Li Y; Liu N; Liu Y; Gai Z
    Stem Cell Res; 2019 Dec; 41():101635. PubMed ID: 31707215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS.
    Ross PJ; Zhang WB; Mok RSF; Zaslavsky K; Deneault E; D'Abate L; Rodrigues DC; Yuen RKC; Faheem M; Mufteev M; Piekna A; Wei W; Pasceri P; Landa RJ; Nagy A; Varga B; Salter MW; Scherer SW; Ellis J
    Biol Psychiatry; 2020 Jan; 87(2):139-149. PubMed ID: 31540669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cell lines from nonaffected parents and monozygotic triplets affected with autism spectrum disorder and epilepsy.
    Ali G; Habbab W; Alkhadairi G; Al-Shaban FA; Stanton LW
    Stem Cell Res; 2022 Dec; 65():102943. PubMed ID: 36272305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.